1090.50GBp-4.22%Mkt Cap: 10.02B $P/E: 20.191d ago
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three seg…
Indicators:|
Key Statistics
Company
Market Cap10.02B $
Enterprise Value13.08B $
Revenue (TTM)6.70B $
Gross Profit4.56B $
Net Income (TTM)679.35M $
Revenue/Share7.728 USD
Last Price1090.50 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees17.0K
CountryGB
SectorHealthcare
IndustryMedical Devices
ISINGB0009223206
Valuation
P/E (Trailing)20.19
P/E (Forward)11.68
PEG1.20
EV/EBITDA9.01
EV/Revenue1.95
P/S1.49
P/B2.31
EPS (TTM)0.57
EPS (Forward)0.93
52W Range
1050.0010% of range1441.50
52W High1441.50 GBp
52W Low1050.00 GBp
Profitability
Gross Margin68.01%
Oper. Margin13.99%
EBITDA Margin21.67%
Profit Margin10.14%
ROE11.82%
ROA5.98%
Growth
Revenue Growth7.40%
Earnings Growth70.40%
Cash Flow & Leverage
Operating CF1.40B $
CapEx (TTM)470.65M $
FCF Margin14.22%
FCF Yield9.51%
Net Debt3.01B $
Net Debt/EBITDA2.07
Balance Sheet
Debt/Equity0.63
Current Ratio2.57
Quick Ratio1.17
Book Value/Sh4.719 GBp
Cash/Share0.6560 GBp
Dividends
Fwd Div Rate0.2900 GBp
Trail. Div Rate0.3910 GBp
Div. Yield2.66%
5Y Avg Yield2.59%
Payout Ratio52.72%
Ex-Div DateMar 26, 2026
Pay Date—
Splits
Last Split9:11
Split DateAug 7, 2000
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1393.61 GBp
Upside (mean)+27.8%
Target Range1204.40 GBp – 1632.02 GBp
GBp1204.40+27.8% to meanGBp1632.02
# Analysts17
Ownership
Shares Out.845.04M
Float839.53M
Insiders0.23%
Institutions72.01%
Technical
SMA 501134.89 (-3.9%)
SMA 2001238.80 (-12.0%)
Beta0.67
S&P 52W Chg20.05%
Avg Vol (30d)2.93M
Avg Vol (10d)3.08M
Technical Indicators
RSI (14)37.8
MACD-4.2407
MACD Signal-3.4395
MACD Hist.-0.8013
BB Upper1168.29 GBp
BB Middle1130.63 GBp
BB Lower1092.96 GBp
BB Width6.66%
ATR (14)28.11 GBp
Vol Ratio (20d)2.08x